Roivant Sciences is a biopharmaceutical company dedicated to accelerating the development of innovative medicines. Founded in 2014, Roivant aims to simplify the complexities of drug development and reduce the timeline associated with bringing new therapies to market, ultimately improving patient outcomes. The company has established a diverse portfolio of over 20 subsidiaries, known as "Vants," each focused on specific medical needs across various therapeutic areas. With a commitment to technological advancement, Roivant integrates data and machine learning into its processes to enhance drug discovery and development efforts. The company values collaboration, innovation, and a patient-centric approach, striving to make a tangible difference in the lives of patients and their families. For those considering a role at Roivant, the culture emphasizes teamwork and a dynamic work environment where ideas can translate into impactful health solutions.